The global blood collection tubes market is poised for robust expansion, with its valuation expected to grow from US$ 2.3 billion in 2023 to US$ 3.6 billion by 2032, registering a compound annual growth rate (CAGR) of 5.4% during the forecast period (2024–2032). This growth is driven by an increase in diagnostic procedures, rising cases of chronic illnesses, and a surge in surgical interventions requiring routine blood analysis. Notably, the increasing adoption of EDTA blood collection tubes for clinical hematology applications is bolstering market momentum.
Market Overview: Crucial Role in Diagnostic Medicine
Blood collection tubes are indispensable tools in clinical and research settings, used for collecting, storing, and transporting blood samples without compromising sample integrity. These tubes are designed with anticoagulants or additives that preserve blood characteristics and prevent clotting, making them critical for accurate laboratory analyses.
Different tube types—such as EDTA tubes, heparin tubes, serum separating tubes, and plasma separation tubes—serve varied diagnostic needs. Among these, EDTA tubes have gained considerable traction due to their reliability in hematology tests and their role in stabilizing platelet-derived extracellular vesicles (EVs), which are pivotal in advanced medical research.
Key Market Drivers
1. Prevalence of Chronic Diseases
A significant rise in conditions such as cancer, tuberculosis (TB), and chronic obstructive pulmonary disease (COPD) has created a sustained demand for diagnostic blood testing. According to the World Health Organization, TB alone caused 1.3 million deaths in 2022, and 10.6 million people globally were diagnosed with the disease. These alarming statistics underscore the importance of frequent diagnostic evaluations, which invariably rely on blood collection systems.
Moreover, the growing burden of non-communicable diseases, particularly in aging populations, continues to fuel the need for accurate and timely diagnosis, further driving market growth.
2. Rising Popularity of EDTA Tubes
EDTA (Ethylenediaminetetraacetic acid) tubes have become the gold standard for hematological testing. These tubes prevent coagulation by binding calcium ions in the blood and are instrumental in procedures like complete blood counts and blood transfusions.
Research by the National Library of Medicine in 2022 emphasized the role of EDTA in stabilizing extracellular vesicles and preserving cell-free RNA integrity during freeze-thaw cycles, making it highly suitable for advanced applications like liquid biopsies and EV research. As the medical field evolves toward precision diagnostics, the demand for EDTA-based tubes is expected to increase significantly.
3. Surge in Surgical Procedures
The rising number of surgeries related to trauma, cardiovascular issues, and oncology has led to a spike in demand for blood donation and transfusion, indirectly propelling the blood collection tubes industry. In such clinical settings, the accuracy and safety of blood sample handling are paramount, further amplifying the use of standardized blood collection systems.
Regional Insights: Asia Pacific Leads Market Expansion
In 2023, Asia Pacific emerged as the leading regional market, fueled by a growing geriatric population, high disease prevalence, and increasing diagnostic testing in countries such as India and China.
India, for example, faces a significant burden of thyroid disorders, affecting over 42 million people, with women disproportionately impacted. These health conditions necessitate routine blood testing, contributing to the region’s dominant market share.
Furthermore, public health campaigns and healthcare infrastructure developments across the region are facilitating better access to diagnostic services, thereby accelerating market expansion.
Competitive Landscape and Technological Advancements
The global blood collection tubes market is witnessing continuous innovation, with key players focusing on enhancing sample stability, reducing contamination risk, and improving automated processing compatibility.
Prominent companies include:
- BD (Becton, Dickinson and Company)
- Greiner AG
- Terumo Corporation
- Abbott
- Cardinal Health Inc.
- Qiagen
- Improve Medical
- Medtronic
- SARSTEDT AG & Co. KG
- Chengdu Rich Science Industry Co., Ltd.
In 2022, Tethis S.p.A. launched See.d, the first universal automated blood sample preparator for liquid biopsy analysis, demonstrating how automation and standardization are revolutionizing sample preparation.
Other notable developments include:
- Immunexpress, Pty Ltd. introduced EDTA-compatible cartridges for sepsis diagnosis in European markets (August 2022).
- Abacus dx launched RNA Complete BCT in partnership with Streck, expanding the portfolio for RNA-based diagnostics (February 2022).
These innovations highlight the industry’s commitment to precision diagnostics and early disease detection, key pillars in modern healthcare.
Market Segmentation Snapshot
By Product Type:
- EDTA Tubes
- Heparin Tubes
- Serum Separating Tubes
- Plasma Separation Tubes
- Others
By Material:
- Plastic (PET, PP, PS, Others)
- Glass
By End-use:
- Healthcare Centers
- Diagnostic Centers
- R&D Centers
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Future Outlook
With increasing healthcare awareness, rising investment in diagnostics, and continuous product innovation, the global blood collection tubes market is on a steady growth trajectory. The market’s potential will be further unlocked by advancements in biomarker research, liquid biopsies, and molecular diagnostics. Key stakeholders—including manufacturers, diagnostic labs, and healthcare providers—must align their strategies to support scalable, efficient, and high-quality blood collection systems. As the world continues to prioritize early diagnosis and preventive healthcare, blood collection tubes will remain foundational to modern medicine.
